Loading clinical trials...
Loading clinical trials...
Establishing a Tumor Bank and Initial Analysis of Germline and Tumor-Related Genetic Alterations in Families With Multiple Lymphoproliferative Malignancies
Conditions
Locations
1
United States
Dana-Farber Cancer Institute
Boston, Massachusetts, United States
Start Date
August 9, 2004
Primary Completion Date
January 1, 2033
Completion Date
January 1, 2033
Last Updated
April 24, 2026
NCT05735717
NCT06667687
NCT07162181
NCT04664179
NCT07239323
NCT05623982
Lead Sponsor
Dana-Farber Cancer Institute
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions